{"nctId":"NCT06675500","briefTitle":"Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery","startDateStruct":{"date":"2024-11-01","type":"ACTUAL"},"conditions":["Atrial Fibrillation (AF)","Magnesium Sulfate","Post Cardiac Surgery Patients"],"count":130,"armGroups":[{"label":"Group A (Study group)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Magnesium sulphate"]},{"label":"Group B (Control group)","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Magnesium sulphate","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* • Elective open heart surgeries for coronary bypass grafting CABG,valvular lesion single or multiple replacement, combined CABG and valvular; with EF in preoperative echo is more than or equal 40%\n\nExclusion Criteria:\n\n* Patients refuse to give informed consent.\n* Emergency open heart surgeries\n* Redo cases.\n* Patients with preoperative serum creatinine level ≥ 1.8 mg/dL\n* Patients with reduced intra/post operative urine output ≤ 1 ml/kg/hour.\n* Patients with Chronic Kidney disease, Renal failure on dialysis\n* Patients with rhythm defects as proved by ECG before administration of Mg/Placebo.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With New Episodes of Atrial Fibrillation","description":"Count of participants developing atrial fibrillation (AF) (episode \\>30 seconds) confirmed by 12-lead ECG or continuous telemetry during hospitalization (≤7 days).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Total ICU Length of Stay","description":"Total duration of ICU admission from postoperative transfer to discharge, measured in days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"0.8"},{"groupId":"OG001","value":"3.5","spread":"1.2"}]}]}]},{"type":"SECONDARY","title":"Total Ventilation Time","description":"mechanical ventilatory support in hours","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.4","spread":"3.1"},{"groupId":"OG001","value":"7.8","spread":"2.1"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With New Postoperative Renal Impairment","description":"Count of participants meeting ≥1 criterion:\n\n1. Postoperative serum creatinine ≥1.8 mg/dL\n2. Requirement of renal replacement therapy (hemodialysis, transient, or permanent)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":10,"n":65},"commonTop":["Hypotension"]}}}